Clinical Trials Browser

Phase 3 × Small Cell Lung Carcinoma × anlotinib × Clear all

NCT04073550 2019-08-29

Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer

Phase 3 Unknown

Small Cell Lung Carcinoma